It is a broadly described annual report of Sun Pharmaceutical Industries Limited in the year of 2000-2001. During the financial year, The Company’s Total Income Rs. 6211 million. Total income increased 29% over last year. Net Profit after Tax for the year Rs. 1352 million. At the net level profit increased 49% over last year. Preference Share Rs. 41. Equity shares intern Rs. 234. The domestic formulation business grew by 22% to Rs 3.70 billion. Export grew by 4% to 1.18 billion.
An interim dividend at @9.5% (previous year @10.5%) p.a. was paid to the preference shareholders, whose names stood on the register of members on 15th March 2001. An interim dividend @50% post bonus (previous year @100% pre-bonus) was paid to the equity shareholders of the Company whose names stood on the register of members on 2nd August 2001.
More Annual Report of Sun Pharmaceutical Industries Limited:
- Annual Report 1999-2000 of Sun Pharmaceutical Industries Limited
- Annual Report 2000-2001 of Sun Pharmaceutical Industries Limited
- Annual Report 2001-2002 of Sun Pharmaceutical Industries Limited
- Annual Report 2002-2003 of Sun Pharmaceutical Industries Limited
- Annual Report 2003-2004 of Sun Pharmaceutical Industries Limited
- Annual Report 2004-2005 of Sun Pharmaceutical Industries Limited
- Annual Report 2005-2006 of Sun Pharmaceutical Industries Limited
- Annual Report 2006-2007 of Sun Pharmaceutical Industries Limited
- Annual Report 2007-2008 of Sun Pharmaceutical Industries Limited
- Annual Report 2008-2009 of Sun Pharmaceutical Industries Limited
- Annual Report 2009-2010 of Sun Pharmaceutical Industries Limited
- Annual Report 2010-2011 of Sun Pharmaceutical Industries Limited
- Annual Report 2011-2012 of Sun Pharmaceutical Industries Limited
- Annual Report 2012-2013 of Sun Pharmaceutical Industries Limited
- Annual Report 2013-2014 of Sun Pharmaceutical Industries Limited
- Annual Report 2014-2015 of Sun Pharmaceutical Industries Limited
- Annual Report 2015-2016 of Sun Pharmaceutical Industries Limited
- Annual Report 2016-2017 of Sun Pharmaceutical Industries Limited